Alloy has numerous resources and tools to help you with your clients weight loss journey
A comprehensive metabolic panel, complete blood count, thyroid function tests, and vitamin levels may be more informative than isolated testosterone measurement in many cases
When taken together, these drugs can significantly increase the risk of hypoglycemia, or low blood sugar
Health Canada approved Wegovy in November 2021, but its taken about two and a half years to bring it to market amid supply shortages of Ozempic, which is only approved to treat Type 2 diabetes but has been prescribed off-label for weight loss
Myth: GLP-1 medications cause thyroid cancer in humans
Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist